Skip to main content

Want a detailed portfolio tracker?

Indaptus Therapeutics (INDP) P/E (2023 - 2026)

Indaptus Therapeutics (INDP) P/E from Oct 2, 2023 to Jul 21, 2026. The TTM Indaptus Therapeutics (INDP) P/E is -4.76. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Indaptus Therapeutics (INDP)

YearP/EChange
2026-4.76+29.14%
2025-3.69-75.60%
2024-15.10-85.70%
2023-105.61N/A

Comparison Indaptus Therapeutics (INDP) P/E with competitors

Indaptus Therapeutics (INDP) P/E is -4.76.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.09%
ENLVEnlivex Ltd0.07-101.57%
FGENFibroGen Inc0.24-105.04%
CHRSCoherus Biosciences Inc0.85-117.83%
FBIOFortress Biotech Inc0.95-119.94%
ORMPOramed Pharmaceuticals Inc1.50-131.58%
AGENAgenus Inc3.01-163.23%
INVAInnoviva Inc3.15-166.26%
VXRTVaxart Inc3.55-174.58%
CRMDCorMedix Inc3.63-176.23%
CVACCureVac N.V.4.45-193.40%
GLPGGalapagos NV4.86-202.08%
SRPTSarepta Therapeutics Inc4.88-202.57%
ABEOAbeona Therapeutics Inc5.39-213.19%
ABUSArbutus Biopharma Corp5.60-217.56%
ZVRAZevra Therapeutics Inc5.89-223.68%
SPROSpero Therapeutics Inc6.23-230.85%
CGENCompugen Ltd6.31-232.65%
RIGLRigel Pharmaceuticals6.87-244.37%
SLXNSilexion Therapeutics Corp7.30-253.28%
OMEROmeros Corporation9.26-294.52%
AUPHAurinia Pharmaceuticals Inc9.58-301.37%
PLXProtalix BioTherapeutics Inc10.89-328.81%
ACADAcadia Pharmaceuticals Inc11.73-346.40%
TBPHTheravance Biopharma Inc12.26-357.61%
ADMAAdma Biologics Inc12.42-360.89%
HRMYHarmony Biosciences Holdings Inc13.82-390.35%
SABSSAB Biotherapeutics Inc14.14-396.99%
NAGENiagen Bioscience Inc14.82-411.31%
INCYIncyte Corp15.82-432.41%
REGNRegeneron Pharmaceuticals Inc15.86-433.13%
PBYIPuma Biotechnology Inc17.32-463.78%
CPRXCatalyst Pharmaceuticals Inc17.44-466.38%
EXELExelixis Inc17.54-468.45%
TGTXTG Therapeutics Inc18.97-498.46%
MDXGMimedx Group Inc20.55-531.79%
XOMAXOMA Royalty Corp22.87-580.58%
ARGXArgen X SE24.30-610.49%
CTMXCytomX Therapeutics Inc24.82-621.48%
XOMAOXOMA Royalty Corp25.34-632.48%
HALOHalozyme Therapeutics Inc25.62-638.34%
XOMAPXOMA Royalty Corp25.67-639.32%
VRTXVertex Pharmaceuticals Inc27.99-688.15%
RPRXRoyalty Pharma plc - Class A28.69-702.71%
SLNOSoleno Therapeutics Inc29.02-709.60%
ASNDAscendis Pharma A/S30.09-732.08%
LGNDLigand Pharmaceuticals Inc - Class B37.91-896.51%
APLSApellis Pharmaceuticals Inc39.02-919.81%
BMRNBiomarin Pharmaceutical Inc42.21-986.85%
KRYSKrystal Biotech Inc45.34-1052.64%
ONCBeiGene Ltd69.54-1561.01%
PHARPharming Group N.V.75.03-1676.25%
TECHBio-Techne Corp101.96-2242.09%
VCELVericel Corp109.92-2409.39%
ALNYAlnylam Pharmaceuticals Inc117.96-2578.39%
GMABGenmab140.29-3047.44%
TLXTelix Pharmaceuticals Ltd162.15-3506.75%
CORTCorcept Therapeutics Inc212.86-4572.03%